Logo image
Fucosylated glycoproteins as markers of liver disease
Journal article   Open access   Peer reviewed

Fucosylated glycoproteins as markers of liver disease

Anand Mehta and Timothy M. Block
Disease markers, v 25(4-5), pp 259-265
01 Jan 2008
PMID: 19126969
url
https://doi.org/10.1155/2008/264594View
Published, Version of Record (VoR)CC BY V4.0 Open

Abstract

Biotechnology & Applied Microbiology Genetics & Heredity Life Sciences & Biomedicine Medicine, Research & Experimental Pathology Research & Experimental Medicine Science & Technology
Changes in N-linked glycosylation are known to occur during the development of various diseases. For example, increased branching of oligosaccharides has been associated with cancer metastasis and has been correlated to tumor progression in human cancers of the breast, colon and melanomas. Increases in core fucosylation have also been associated with the development of hepatocellular carcinoma (HCC). Recently, changes in both the total serum glycome and the glycosylation of specific IgG molecules have been observed in people with liver fibrosis and cirrhosis. The mechanisms by which changes in glycosylation are observed and their use as biomarkers of disease will be discussed.

Metrics

9 Record Views
62 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Biotechnology & Applied Microbiology
Genetics & Heredity
Medicine, Research & Experimental
Pathology
Logo image